West Pharmaceutical Services Inc (WST)
NYSE · Healthcare · Medical Instruments & Supplies
West Pharmaceutical Services Inc is a Healthcare company with a market capitalization of $24.79B, a trailing P/E ratio of 47.0, and a dividend yield of 0.25%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 23, 2026 | $2.13 | $1.68 | +26.8% |
| Q4 2025 | February 12, 2026 | $2.04 | $1.83 | +11.5% |
| Q3 2025 | October 23, 2025 | $1.92 | $1.67 | +15.0% |
| Q2 2025 | July 24, 2025 | $1.84 | $1.54 | +19.5% |
| Q1 2025 | April 24, 2025 | $1.45 | $1.26 | +15.1% |
| Q4 2024 | February 13, 2025 | $1.82 | $1.71 | +6.4% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is West Pharmaceutical Services Inc's market cap?
As of June 29, 2026, West Pharmaceutical Services Inc (WST) has a market capitalization of $24.79B.
What is West Pharmaceutical Services Inc's P/E ratio?
West Pharmaceutical Services Inc trades at a trailing price-to-earnings (P/E) ratio of 47.0. Its forward P/E is 40.8.
Does West Pharmaceutical Services Inc pay a dividend?
Yes — West Pharmaceutical Services Inc pays a dividend yielding 0.25%, an annual payout of $0.86 per share.
What sector is WST in?
West Pharmaceutical Services Inc is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was West Pharmaceutical Services Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), West Pharmaceutical Services Inc reported revenue of $3.07B and net income of $493.70M.
Ask your own questions about WST
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.